Εμφάνιση απλής εγγραφής

dc.creatorPrapa P., Papathanasiou I.V., Bakalis V., Malli F., Papagiannis D., Fradelos E.C.en
dc.date.accessioned2023-01-31T09:50:39Z
dc.date.available2023-01-31T09:50:39Z
dc.date.issued2021
dc.identifier10.14740/wjon1371
dc.identifier.issn19204531
dc.identifier.urihttp://hdl.handle.net/11615/78357
dc.description.abstractBackground: Patients with lung cancer often experience multiple symptoms associated with both the disease itself and the treatment. The disease and therapy-related adverse effects may lead to poor quality of life (QoL) and increased psychological distress. The aim of this study was to investigate the QoL and psychological distress of patients with lung cancer. The relationship between these two aspects was also an area of focus. Methods: This was a quantitative descriptive study. Data collection was done using a self-complementary tool. The data were collected between February and March 2020. The sample consisted of 135 patients with lung cancer who were undergoing chemotherapy in 1-day clinic in Athens (a sample of convenience). Results: Regarding the QoL of our sample, we observed that the mean score of the physical health component of SF-12 was 38.17 ± 9.94 and of the mental health component was 45.63 ± 11.80. Asregards the psychological distress of our sample, we observed that the mean score for depression was 4.55 ± 5.04, for anxiety was 3.84 ±4.17 and for stress was 5.21 ± 5.01. Conclusion: As is clear from the results, lung cancer patients reported poor QoL and increased rates of psychological distress. Articles © The authors | Journal compilation © World J Oncol and Elmer Press Inc™ | www.wjon.org This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly citeden
dc.language.isoenen
dc.sourceWorld Journal of Oncologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85109866468&doi=10.14740%2fwjon1371&partnerID=40&md5=2ddc874912af920c6c6151dec3a60606
dc.subjectantineoplastic agenten
dc.subjecthemoglobinen
dc.subjectadulten
dc.subjectanxietyen
dc.subjectArticleen
dc.subjectcancer chemotherapyen
dc.subjectcontrolled studyen
dc.subjectdepressionen
dc.subjectdistress syndromeen
dc.subjectdrug efficacyen
dc.subjectdrug safetyen
dc.subjectdrug tolerabilityen
dc.subjectfemaleen
dc.subjecthematocriten
dc.subjecthumanen
dc.subjectleukocyte counten
dc.subjectlung canceren
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmental healthen
dc.subjectmiddle ageden
dc.subjectpersonal experienceen
dc.subjectphysiological stressen
dc.subjectquality of lifeen
dc.subjectquantitative analysisen
dc.subjectquestionnaireen
dc.subjectShort Form 12en
dc.subjectsmall cell carcinomaen
dc.subjectElmer Pressen
dc.titleQuality of Life and Psychological Distress of Lung Cancer Patients Undergoing Chemotherapyen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής